Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan versus conventional therapy in chronic heart failure
ChiCTR-IPR-15005964Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levosimendan in chronic heart failure (CHF) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: cardiac troponin T, insulin-like growth factor 1 and 1 more. Started Apr 2013; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR-IPR-15005964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005964.